In addition to OCT4, the mRNA expression and nuclear localization of Nanog, a downstream target of OCT4 [34], were also suppressed by penfluridol treatment in ccRCC cells (Supplementary Fig. 6). This evidence concerns the gene POU5F1 and nonpapillary renal cell carcinoma.